PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy Adults
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 35
- Registration Number
- NCT06466473
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 118
- Registration Number
- NCT06465368
- Locations
- 🇨🇳
Mackay Memorial Hospital, Taipei, Taiwan
🇨🇳Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan
🇦🇺Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 500
- Registration Number
- NCT06462014
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
- Conditions
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 48
- Registration Number
- NCT06462235
- Locations
- 🇺🇸
Norton Children's Hospital, Louisville, Kentucky, United States
🇺🇸Novak Center for Children's Health, Louisville, Kentucky, United States
🇺🇸University of Louisville, Norton Children's Research Institute, Louisville, Kentucky, United States
A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT06453356
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC dba QPS-MO, Springfield, Missouri, United States
🇺🇸Bio-Kinetic Clinicals Applications LLC DBA QPS-MO Patient Screening and Recruitment Center Center), Springfield, Missouri, United States
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 4
- Registration Number
- NCT06448364
- Locations
- 🇵🇷
Hospital Oncológico Dr. Isaac González-Martinez, Rio Piedras, Puerto Rico
🇺🇸NEXT Oncology, San Antonio, Texas, United States
🇵🇷Pan American Center for Oncology Trials, LLC, Rio Piedras, Puerto Rico
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
- Conditions
- Interventions
- Drug: PF-07934040Combination Product: GemcitabineCombination Product: CetuximabCombination Product: FluorouracilCombination Product: PembrolizumabCombination Product: Nab-paclitaxelCombination Product: OxaliplatinCombination Product: pemetrexedCombination Product: LeucovorinCombination Product: CisplatinCombination Product: BevacizumabCombination Product: PaclitaxelCombination Product: Carboplatin
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 330
- Registration Number
- NCT06447662
- Locations
- 🇺🇸
Highlands Oncology Group, PA, Rogers, Arkansas, United States
🇺🇸Highlands Oncology Group, Springdale, Arkansas, United States
🇺🇸City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California, United States
A Study About Modified RNA Vaccines Against Influenza in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1202
- Registration Number
- NCT06436703
- Locations
- 🇺🇸
Clinical Research Professionals, Chesterfield, Missouri, United States
🇺🇸Artemis Institute for Clinical Research, San Diego, California, United States
🇺🇸Duke Vaccine and Trials Unit, Durham, North Carolina, United States
A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20000
- Registration Number
- NCT06418529
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine
- Conditions
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 528
- Registration Number
- NCT06412965
- Locations
- 🇺🇸
Pfizer, New York, New York, United States